Helicobacter canis bacteraemia in a rheumatoid arthritis patient treated with tofacitinib: case report and literature review
Open Access
- 8 April 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Annals of Clinical Microbiology and Antimicrobials
- Vol. 20 (1), 1-7
- https://doi.org/10.1186/s12941-021-00426-x
Abstract
Non-Helicobacter pylori species (NHPS) are newly emerging bacteria that naturally inhabit birds and mammals apart from humans and rarely cause diseases in humans. In recent years, a rise in the number of cases associated with NHPS infections in humans has been observed. Among them, infections with Helicobacter (H.) canis are sporadic and challenging to recognise clinically. To date, ten cases of H. canis infections in mainly immunocompromised humans have been reported in the literature. Transmission pathway is most likely zoonotic via the faecal-oral route during close contacts with dogs and cats or may result from a contaminated sheep milk intake. No clear guidelines for successful antibiotic regimen are known. Important additional risk factor for infection might be biologic agents and Janus kinase inhibitors (JAKi) used in the treatment of rheumatoid arthritis (RA) and other conditions. Herein we present the first case of H. canis bacteraemia in a RA patient treated with novel JAKi tofacitinib. A 65-year-old female patient with RA and rituximab-induced hypogammaglobulinemia treated with tofacitinib, methotrexate, and methylprednisolone came to a planned visit in our outpatient rheumatology clinic. She presented with a history of back pain that significantly worsened 2 days before visit. She had numbness and tingling sensation in both legs and muscle weakness. Neurological examination was within a normal range. The patient was afebrile, had no chills, and was haemodynamically stable. She was in close contact with her pet dogs. Laboratory examination showed increased markers of inflammation. She was found to have H. canis bacteraemia with underlying multilevel degenerative lumbar spinal stenosis. Identification of H. canis was performed by MALDI-TOF MS and 16 S rRNA gene sequence analysis of isolate from subcultured positive aerobic blood culture bottles. Antimicrobial susceptibility testing showed low minimum inhibitory concentrations to amoxicillin-clavulanate, cefotaxime, ceftriaxone, meropenem, and gentamicin. She was treated with combined antibiotic regimen (ceftriaxone, doxycycline) for 14 days, which resulted in total remission of the infection. Clinicians should recognise H. canis infection risk in patients with recent pet exposure and predisposing factors such as immunodeficiency disorders or diseases that demand immunosuppressive drug therapy. A minimum of two weeks of antibiotic therapy is suggested.This publication has 31 references indexed in Scilit:
- Biologic Therapies in Rheumatoid Arthritis and the Risk of Opportunistic Infections: A Meta-analysisClinical Infectious Diseases, 2014
- Helicobacter canis bacteremia in a renal transplant patientTransplant Infectious Disease, 2013
- Incidence of Hypogammaglobulinemia in Patients Receiving Rituximab and the Use of Intravenous Immunoglobulin for Recurrent InfectionsClinical Lymphoma Myeloma and Leukemia, 2013
- Helicobacter canis Bacteremia in a Patient with Fever of Unknown OriginJournal of Clinical Microbiology, 2013
- First detection of Helicobacter canis in chronic duodenal ulcerations from a patient with Crohnʼs diseaseInflammatory Bowel Diseases, 2011
- Persistent Helicobacter canis Bacteremia in a Patient with Gastric LymphomaInfection, 2009
- Helicobacter canisbacteraemia in a 7-month-old childFEMS Immunology & Medical Microbiology, 2007
- First Case of Bacteremia and Multifocal Cellulitis Due to Helicobacter canis in an Immunocompetent PatientJournal of Clinical Microbiology, 2006
- Recurrent Bacteremia and Multifocal Lower Limb Cellulitis Due toHelicobacter‐Like Organisms in a Patient with X‐Linked HypogammaglobulinemiaClinical Infectious Diseases, 2001
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988